HIV Articles  
Back 
 
 
Safety, efficacy and pharmacokinetic of Darunavir/Ritonavir
containing regimen in pregnant HIV-infected women
 
 
  Reported by Jules Levin
 
19th Conference on Retroviruses and Opportunistic infections 5-8 March, 2012, Seattle, WA, USA
 
Courbon E1, Matheron S2, Mandelbrot L3, Tubiana R4, Marcelin AG5, Faucher P6, Descamps D7, Peytavin G1
1Clinical Pharmacy Departement, AP-HP, Bichat Claude Bernard Hospital and EA4409, Paris 7 University, Paris, France. 2. Infectious Diseases Department, AP-HP, Bichat Claude Bernard Hospital, Paris, France. 3. Obstetric & Gynaecology Department, AP-HP, Louis Mourier Hospital, Colombes, France. 4. Infectious Diseases Department, AP-HP, Pitie-Salpretriere, Paris, France. 5. Virology Department, AP-HP, Pitie-Salpretriere, Paris, France. 6. Obstetric & Gynaecology Department, AP-HP, Bichat Claude Bernard Hospital, Paris, France. 7. Virology Department, AP-HP, Bichat Claude Bernard Hospital and EA4409, Paris 7 University, Paris, France

HIV1.gif

HIV2.gif

HIV3.gif

HIV4.gif

HIV5.gif

HIV6.gif

HIV7.gif

HIV8.gif

HIV9.gif

HIV10.gif

HIV11.gif

 
 
 
 
  iconpaperstack view older Articles   Back to Top   www.natap.org